TruthArchive.ai - Related Video Feed

The speaker, a physician and psychiatrist, states that medicine faces the difficulty that most disease is preventable, but the medical field profits from curing or ameliorating disease with medications and procedures. The speaker claims that the medical field does not profit from preventing disease by encouraging people to socialize or exercise.

The speaker discusses the relationship between profits and cancer treatment in the United States. They mention a study that found chemotherapy to be ineffective 97% of the time, but it is still used because doctors profit from it. The speaker explains how doctors receive financial incentives for prescribing chemotherapy drugs. They argue that the pharmaceutical industry has control over cancer treatment and that the medical system prioritizes drugs and surgery over alternative approaches. The speaker suggests that funding for cancer research should also go towards nutritional, homeopathic, acupuncture, and naturopathic research. They criticize the for-profit nature of the medical industry and its impact on patient outcomes.

The speaker claims that the Rockefellers control major drug companies worldwide, with representatives from banks and oil companies on their boards. They aim to control all aspects of biology, from birth to death, including hormones, glands, and genes. The Rockefellers gained control of the medical industry in 1910, leading to the current expensive healthcare system in the US. Cancer treatment is particularly costly, with little promise of a cure. The speaker suggests that these monopolies are interconnected and controlled by a group of elitists known as the world order people. (134 words)

My name is Gwen Olsen, a former pharmaceutical industry veteran. The industry focuses on maintaining diseases, not curing them. Psychiatric drugs keep patients reliant on medications for life. Many drugs are no more effective than placebos, with exercise often proving more beneficial. The pharmaceutical industry prioritizes profit over patient well-being, pushing unnecessary medications. It's crucial to educate yourself on alternative health options to avoid becoming a lifelong pharmaceutical customer. Take charge of your health, share knowledge, and prevent loved ones from falling victim to unnecessary medications. Thank you. Translation: The speaker, Gwen Olsen, discusses the pharmaceutical industry's focus on maintaining diseases rather than curing them, highlighting the ineffectiveness of many drugs and the importance of educating oneself on alternative health options.

Dr. David Graham, FDA associate director, discusses Vioxx's heart attack risks. Despite studies showing increased risks, FDA did not act promptly. He highlights FDA's flawed drug safety system, emphasizing the need for a more patient-centered approach. Regulatory obstacles and conflicts of interest hinder effective drug safety measures, leaving Americans vulnerable to harm. Graham calls for a reevaluation of FDA's structure and priorities to prevent future drug safety catastrophes.

The speaker, a former pharmaceutical sales rep, shares their disillusionment with the industry after discovering corruption and falsified safety data. They recount their experience with vaccines and their concerns about the lack of rigorous safety studies and the toxic additives, such as aluminum, in childhood vaccines. The speaker highlights the high rates of illness in American children compared to other developed countries and attributes it to the profit-driven nature of the pharmaceutical industry. They discuss the influence of pharmaceutical companies on the media and the lack of liability for vaccine manufacturers. The speaker emphasizes the need for more research and information before mandating vaccines, citing the potential risks involved.

Dr. David Graham discusses the Vioxx scandal, highlighting FDA failures in addressing heart attack risks associated with the drug. Despite evidence of increased heart attack risks, FDA did not take appropriate action, resulting in an estimated 100,000 excess cases. Graham criticizes FDA's focus on drug approval over safety, citing conflicts of interest and a culture that prioritizes industry interests. He argues for a more proactive and patient-centered approach to drug safety regulation.

Peter Goertje, Director of the Nordic Cochrane Center, reveals that prescription drugs are the third leading cause of death in the US, resulting in around 200,000 deaths annually. Half of these deaths occur due to side effects, while the other half are caused by errors made by doctors who are unaware of the numerous warnings and precautions associated with each drug. Goertje also highlights the corrupt practices of the pharmaceutical industry, comparing them to organized crime. He emphasizes the need for patients to reduce their reliance on drugs, as they often have harmful side effects and can lead to a decline in health, particularly in the elderly.

The speaker discusses the pharmaceutical industry and its problems. They explain that the industry has struggled to keep up with the complexity of molecular biology and the changing face of capitalism. The speaker highlights how the industry has become powerful and profitable by increasing prices and creating "me too" drugs. They criticize the lack of transparency and the influence of the industry on decision-making at various levels. The speaker emphasizes the need for better pharmacovigilance and a change in medical education to prioritize understanding the dangers of medications. They also address concerns about the industry and the role of doctors.

Pharma whistleblower Brigham Bueller exposes the pharmaceutical industry's broken incentives and aims to empower patients. According to Bueller, the current system is failing to prevent chronic diseases because the industry profits from them. He asserts that expecting insurance or pharmaceutical companies to prioritize the well-being of individuals is a mistake. Bueller emphasizes that this issue transcends politics and is a matter of humanity, expressing hope that the system can be fixed.

The speaker states they decided to break the system, referring to drug companies, which they describe as the most powerful lobby in the world. They claim drug companies have tremendous power over the Senate, the House, governors, and everybody. The speaker notes that drug companies spend billions of dollars. Despite this, the speaker says they don't care and must do what's right.

The speaker brings up the fact that the pandemic created many new billionaires in the pharmaceutical industry. They mention that pharmaceutical companies funded the 2020 election and made huge profits, with Pfizer alone making $100 billion. They also highlight that the public funded the development of vaccines but did not benefit from the profits. The speaker questions the economic system where companies benefit from crises, leading to perpetual crises that serve the interests of the elite rather than ordinary people.

It used to be that pharmaceutical companies were working with the doctors. Now unfortunately, companies are captured by the price of the stock. Know, venture capitalist owned pharmaceutical companies. They owned the CR or the clinical research organizations. They owned the site. They owned the institutional review board. They owned the advertising, the marketing. They influenced through the media. And so unfortunately, there's a big it's a it's a loaded question, but it's a big market. And what we saw this pandemic was the price of the stock mattered more than the price of a life.

The speaker discusses the controversy surrounding statins, a widely prescribed cholesterol-lowering drug. They explain that the rise in statin prescriptions is due to changes in guidelines and industry influence. The speaker highlights concerns about industry bias in statin trials and the lack of transparency in sharing data on side effects. They also discuss how drug companies market statins by exaggerating benefits and silencing dissenting views. The speaker shares their own experience with a controversial TV program on statins and the backlash they faced. They conclude by emphasizing the importance of providing patients with honest and transparent information to make informed decisions about their medications.

Pharmaceutical companies generate over two-thirds of their profits in the United States, despite the U.S. accounting for only 4% of the world's population. The speaker expresses respect for pharmaceutical companies and their leadership. They believe these companies successfully convinced people for many years that the existing system was fair, even though the reasons why were not well understood. The speaker claims to have figured out the reasons behind this.

The speaker claims that the Rockefellers control major drug companies worldwide, with representatives from banks and oil companies on their boards. They aim to control all aspects of biology, from birth to death, including hormones, glands, and genes. The Rockefellers gained control of the medical industry in 1910, leading to the current expensive healthcare system in the US. Cancer treatment is particularly costly, with little promise of a cure. The speaker suggests that these monopolies are interconnected and controlled by a group of elitists known as the world order people. (134 words)

In an interview with John Abramson, a Harvard lecturer and expert in drug litigation, he discusses how America's commercialization of medical knowledge has led to the highest healthcare expenditure with the worst health outcomes. The country has experienced a decline in life expectancy and an increase in chronic diseases. Abramson attributes this to drug companies prioritizing profit over providing the best treatment and controlling information about their drugs. He highlights that prescribed medications are the third leading cause of death globally. He also connects these issues to the neoliberal economic model promoted by figures like Ronald Reagan, Margaret Thatcher, and economist Milton Friedman, who believed that corporations should prioritize profits over people. This mindset helps explain the current state of healthcare. The COVID mRNA vaccine mandates have further exposed this issue.

We're paying too much for drugs compared to other countries, and existing laws make it hard to lower costs. The middlemen in the drug industry are profiting significantly without adding value. We're going to eliminate these middlemen to reduce drug prices to unprecedented levels. This topic dominated our discussions with executives and others involved.

The speaker suggests that pharmaceutical companies want people to continuously take vaccines, even as they become sicker. They claim that these companies also acquire drugs to treat the injuries caused by the vaccines. For example, before rolling out COVID-19 vaccines for children, one of the companies acquired drugs to treat blood clots in children, which they believe the vaccines may cause. The speaker also mentions a large acquisition by Pfizer for novel cancer treatments, implying that they will cause the cancers they treat. The speaker concludes that pharmaceutical companies want people to be sick and dependent on their medications.

The speaker states they decided to break the system, referring to drug companies, which they describe as the most powerful lobby in the world with tremendous power over the Senate, the House, governors, and everybody. The speaker notes that drug companies spend billions of dollars. The speaker claims they don't care and have to do what's right.

The discussion traces the alleged dark origins and long-running influence behind modern medicine and vaccines, framing today’s pharmaceutical system as the culmination of a century-long strategy led by powerful interests. - Rockefeller’s role is presented as foundational. Speaker 0 describes John D. Rockefeller becoming America’s first billionaire in 1913 and using strategic philanthropy through the Rockefeller Institute for Medical Research (1901) and the Rockefeller Foundation (1913) to shape Western medicine toward laboratory-based, drug-centered approaches. The narrative claims this shift marginalized herbalism, naturopathy, homeopathy, and holistic remedies, promoting a model in which a pill is developed for every illness and patients remain chronically ill to sustain repeat business. - The early to mid-20th century is characterized as a period of regulatory capture and a pivot to synthetic, patentable drugs. From the 1920s to the 1940s, oil and chemical companies supposedly moved into synthetic drugs with Rockefeller guidance, removing incentives to patent natural remedies while patenting synthetic ones. This, the speaker argues, created a profit motive to treat illness as a recurring revenue stream. - Regulatory capture and the FDA’s evolution are discussed. The claim is that the FDA became more of a gatekeeper dependent on the industry it regulates, with former pharma executives and consultants filling key roles and rubber-stamping drugs. The only notable counterpoint highlighted is Doctor Francis Kelsey, who reportedly blocked the thalidomide approval in the 1960s, preventing birth defects in the United States and illustrating a brief period when public safety was prioritized. - The subsequent decades are summarized as intensifying industry influence. The 1970s are described as a time when pharmaceutical funding of clinical trials and lobbying expanded, and the 1980 Bayh-Dole Act is cited as enabling private patenting of publicly funded research, increasing collaboration between universities and industry and training medical professionals to favor pharmaceuticals. The 1990s are marked by direct-to-consumer advertising on U.S. television, which allegedly shifted patient behavior and doctor prescribing patterns toward medications advertised directly to the public. - Whistleblower testimony is invoked to illustrate ongoing concerns about drug safety and industry practices. A whistleblower recounts bribes and perks tied to drug promotion, including lavish gifts and trips to doctors, and asserts that patients are often treated as a means to profit for corporations. - The conversation shifts to vaccine safety and regulatory issues. The discussion includes claims about the COVID-19 vaccines, with assertions that the FDA acknowledges a number of child deaths, and a reference to an autopsy-based analysis by Dr. Peter McCullough suggesting a high proportion of vaccine-related deaths in examined cases. There is mention that Dr. McCullough faced professional pushback. - The importance of gut health and the microbiome is emphasized as a counterpoint to pharmaceutical-centric medicine. Speaker 3 argues that gut microbiome diversity is linked to many chronic conditions and aging, and cites the benefits of fermentation and kimchi. A specific emphasis is placed on kimchi as having a broad spectrum of beneficial bacteria and on the purported anti-aging effects observed in cell studies. - Kim Bright of Brightcore Nutrition advocates kimchi-based products (Kimchi One) as a practical approach to support gut health and overall well-being, describing customer testimonials about improved digestion, immune function, skin and hair health, and weight management. She argues for the daily use of gut-supporting probiotics, especially after antibiotic use, and asserts that antibiotics can disrupt gut flora, necessitating restoration of beneficial bacteria. - The speakers discuss consumer engagement and the role of direct customer contact, contrasting it with impersonal pharmaceutical industry practices. They express optimism about changes in medicine and a desire to reduce reliance on processed foods and large pharmaceutical advertising, hoping for reforms and greater transparency. Throughout, the tone asserts a pervasive influence of Rockefeller-era strategies on today’s medical and vaccine landscape, while promoting kimchi-based approaches as a healthier counterbalance and offering products as a practical embodiment of that stance.

The speaker brings up the fact that the pandemic created many new billionaires in the pharmaceutical industry. They mention that pharmaceutical companies funded the 2020 election and made huge profits, with Pfizer alone making $100 billion. They also highlight that the public funded the development of vaccines but didn't receive the profits. The speaker questions the economic system where companies benefit from crises, leading to perpetual crises that serve the interests of the elite rather than ordinary people.

The speaker brings up the fact that the pandemic created many new billionaires in the pharmaceutical industry. They mention that pharmaceutical companies funded the 2020 election and made huge profits, with Pfizer alone making $100 billion. They also highlight that the public funded the development of vaccines but didn't benefit from the profits. The speaker questions the economic system where companies benefit from crises, suggesting it perpetuates a divide between the interests of ordinary people and the elite.

The speaker, who used to work in the pharmaceutical industry, criticizes the industry for prioritizing profit over people's health. He shares his own experiences of being involved in corruption and unethical practices. He highlights the lack of transparency and the influence of the industry on doctors and politicians. He also discusses the overprescription of medication to children, particularly psychotropic drugs, and the harmful effects they can have. The speaker calls for public awareness and action to hold the pharmaceutical industry accountable and protect the health of future generations.

The discussion traces a long, shadowy arc in the development of modern vaccines and medicine, arguing that rapid COVID-19 vaccine progress rests on over a century of influence by powerful interests rather than sudden breakthroughs. - The narrative centers on John D. Rockefeller, who became America’s first billionaire in 1913, the same year the Federal Reserve was created. It frames Rockefeller as leveraging his oil wealth to monopolize medicine, promoting prescription drugs while vilifying natural and holistic remedies. The claim is that Rockefeller used strategic philanthropy (Rockefeller Institute for Medical Research, established 1901; Rockefeller Foundation, 1913) to push laboratory-based, drug-centered medicine, marginalize herbalism and naturopathy, and steer doctors toward pharmaceuticals. The effect, according to the speakers, was to keep people sick so they would return for ongoing treatments rather than cures. - The timeline continues with the rise of the pharmaceutical industry from the 1920s to 1940s, described as moving into synthetic drugs with Rockefeller guidance. Natural remedies were said to be non-patentable while synthetic drugs could be patented, creating a business incentive for ongoing, chronic treatment rather than cures. - The conversation shifts to regulatory dynamics, arguing that regulation became regulatory capture from the 1930s to 1960s, with the FDA functioning as a gatekeeper increasingly populated by former pharma professionals. The FDA’s integrity is debated through the example of Dr. Francis Kelsey, who resisted approving thalidomide; the drug was later linked to birth defects worldwide, and Kelsey’s stance is presented as a rare early stand for public safety. - In the 1970s and 1980s, the narrative asserts growing corporate influence: pharma lobbies expand, advertising budgets explode, and medicine becomes a growth industry. The Bayh-Dole Act of 1980 is cited as enabling private patents on publicly funded research, tying universities to pharma interests and shaping medical education toward pharmaceutical solutions. Direct-to-consumer advertising is highlighted as a turning point in the 1990s, pressuring doctors through patient demand spurred by TV ads. - The discussion includes a first-hand account from a former pharmaceutical sales representative, Lisa Prada, who describes bribes and perks (golf outings, concerts, strip clubs, etc.) to influence prescribing, and asserts that patients were often treated as means to corporate ends. - Kim Bright, founder of Brightcore Nutrition, joins to discuss current health issues, arguing that the pharmaceutical industry prioritizes profits over patient well-being. She notes that the Rockefeller Foundation funded COVID-19 vaccine efforts (she cites $55 million) and argues the foundation and industry continued to push medical interventions globally. She notes that the FDA’s public acknowledgment of COVID vaccine-related child deaths is incongruent with whistleblowers’ claims and autopsy data. - The program underscores the idea that prescription drugs are the third leading cause of death in the United States and Europe, citing studies on gut microbiome disruption from medications like antibiotics and acid-reducing drugs (dysbiosis) as a major contributor to chronic disease. - The gut microbiome is emphasized as central to health. Dr. David Perlmutter’s work on the gut-brain connection is referenced, including criticism faced for linking diet and fermented foods to health outcomes. Kimchi is highlighted as a powerful antimicrobial and a potential anti-aging agent in cellular studies. The hosts discuss kimchi’s health benefits, including improved digestion, immune function, and weight management. - Brightcore promotes Kimchi One capsules as a convenient alternative for Americans who dislike traditional kimchi, claiming benefits such as reduced bloating, better digestion, improved hair and skin, and weight loss. A discount offer is advertised: 25% off online, up to 50% off with a phone order, free shipping, and a free vitamin D3 with the first 100 callers, using the code provided. - The conversation closes with reflections on the do-not-mistake-the-system dynamic, optimism about changes in medicine, and calls for removing dependency on processed foods and advertising-driven medicine, with an acknowledgment of RFK Jr.’s activism against pharmaceutical ads on television.